High Tech / IP and Licensing
Protecting intellectual property is a critical issue in technology companies. The need for this kind of protection varies from venture to venture and depends on its sphere of activity, each with its own unique needs.
The firm provides intellectual property legal services to technological incubators, technology transfer companies, and international and local companies operating in the fields of hardware, software, communications, energy, internet, new media, cleantech, life sciences, and biotechnology.
Our work in this field includes forging a company’s business strategy with regard to intellectual property. We also draft and draw up a variety of agreements relating to the design, development, and realization of intellectual property assets, including confidentiality agreements, authorizations, licenses, sub-licenses, and user licenses, as well as various forms of strategic cooperation in the development and commercialization of intellectual property. In addition, we advise companies on IP matters in merger and acquisition transactions and provide representation to such companies when disputes arise.
Our firm also possesses considerable experience handling the unique aspects of online activities, including copyrights, counterfeiting, terms of use, slander, and privacy policy.
Insights & News - High Tech / IP and Licensing:
Determining Intellectual Property Value for Israeli Tax Purposes during a Sale between Related Parties
A sale of intellectual property between related parties requires advance planning and preparation in order to avoid tax exposures in Israel.
Barnea: Representing Pronto Diagnostics and Owners in Sale to Novolog
Sagi Gross and Dor Levi-Tam represented Pronto Diagnostics and its owners in a transaction to sell control of the company to Novolog. Pronto operates in the field of molecular genetic diagnostics.
Barnea: Representing Neve Pharma in Sale to Diplomat for NIS 81 Million
Neve Pharma is engaged in the development, marketing, and sale of nutritional supplements, as well as medical accessories in the ENT field. Sixty-five percent of the company was recently sold to the public company Diplomat for NIS 81 million. Neve Pharma was represented by Sagi Gross, Dor Levi-Tam, and Izabel Pashayev in the transaction.
High Tech / IP and Licensing
Protecting intellectual property is a critical issue in technology companies. The need for this kind of protection varies from venture to venture and depends on its sphere of activity, each with its own unique needs.
The firm provides intellectual property legal services to technological incubators, technology transfer companies, and international and local companies operating in the fields of hardware, software, communications, energy, internet, new media, cleantech, life sciences, and biotechnology.
Our work in this field includes forging a company’s business strategy with regard to intellectual property. We also draft and draw up a variety of agreements relating to the design, development, and realization of intellectual property assets, including confidentiality agreements, authorizations, licenses, sub-licenses, and user licenses, as well as various forms of strategic cooperation in the development and commercialization of intellectual property. In addition, we advise companies on IP matters in merger and acquisition transactions and provide representation to such companies when disputes arise.
Our firm also possesses considerable experience handling the unique aspects of online activities, including copyrights, counterfeiting, terms of use, slander, and privacy policy.
Insights & News - High Tech:
Determining Intellectual Property Value for Israeli Tax Purposes during a Sale between Related Parties
A sale of intellectual property between related parties requires advance planning and preparation in order to avoid tax exposures in Israel.
Barnea: Representing Pronto Diagnostics and Owners in Sale to Novolog
Sagi Gross and Dor Levi-Tam represented Pronto Diagnostics and its owners in a transaction to sell control of the company to Novolog. Pronto operates in the field of molecular genetic diagnostics.
Barnea: Representing Neve Pharma in Sale to Diplomat for NIS 81 Million
Neve Pharma is engaged in the development, marketing, and sale of nutritional supplements, as well as medical accessories in the ENT field. Sixty-five percent of the company was recently sold to the public company Diplomat for NIS 81 million. Neve Pharma was represented by Sagi Gross, Dor Levi-Tam, and Izabel Pashayev in the transaction.